Human Molecular Genetics Advance Access published online on June 25, 2008
Human Molecular Genetics, doi:10.1093/hmg/ddn184
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A common STAT4 risk haplotype for Systemic Lupus Erythematosus is over-expressed, correlates with anti-dsDNA production and shows additive effects with two IRF5 risk alleles
1 Molecular Medicine, Department of Medical Sciences, Uppsala University, SE-75185 Uppsala, Sweden 2 Section of Rheumatology, Department of Medical Sciences, Uppsala University, SE-75185 Uppsala, Sweden 3 McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, H3A 1A4, Canada 4 Department of Surgical Sciences, Uppsala University SE-7518 Uppsala, Sweden 5 Department of Medicine, Rheumatology Unit, Karolinska Institutet/Karolinska University Hospital, SE-77176 Stockholm, Sweden 6 Department of Rheumatology, Lund University, SE-22100, Lund 7 Institute of Laboratory Medicine Section of MIG, Lund University, SE-22100, Lund, Sweden 8 Department of Rheumatology, University Hospital, SE-901 85 Umeå, Sweden 9 Department of Clinical Immunology, University Hospital, SE-901 85 Umeå, Sweden 10 Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden 11 Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Texas, USA 12 Department of Human Genetics, McGill University, Montreal, Quebec, Canada
* Corresponding author: Ann-Christine Syvänen, Department of Medical Sciences, Uppsala University, Molecular Medicine, Entrance 70, Research Department 2, 3rd floor, Uppsala University Hospital, 75185 Uppsala, Sweden. Phone: +46-18-6112959, Fax +46-18-55 36 01, E-mail: Ann-Christine.Syvanen{at}medsci.uu.se
Received March 16, 2008; Revised June 14, 2008; Accepted June 23, 2008
Systemic Lupus Erythematosus (SLE) is the prototype autoimmune disease where genes regulated by type I interferon (IFN) are over-expressed and contribute to the disease pathogenesis. Because STAT4 plays a key role in the type I IFN receptor signaling, we performed a candidate gene study of a comprehensive set of single nucleotide polymorphism (SNPs) in STAT4 in Swedish patients with SLE. We found that ten out of 53 analyzed SNPs in STAT4 were associated with SLE, with the strongest signal of association (p=7.1 x 10–8) for two perfectly linked SNPs rs10181656 and rs7582694. The risk alleles of these ten SNPs form a common risk haplotype for SLE (p=1.7 x 10–5; OR=1.71). According to conditional logistic regression analysis the SNP rs10181656 or rs7582694 accounts for all of the observed association signal. By quantitative analysis of the allelic expression of STAT4 we found that the risk allele of STAT4 was over-expressed in primary human cells of mesenchymal origin, but not in B-cells, and that the risk allele of STAT4 was over-expressed (p=8.4 x 10–5; OR=1.59) in cells carrying the risk haplotype for SLE compared to cells with a non-risk haplotype. The risk allele of the SNP rs7582694 in STAT4 correlated to production of anti-dsDNA antibodies and displayed a multiplicatively increased, 1.82-fold risk of SLE with two independent risk alleles of the IRF5 gene.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A-K Abelson, A M Delgado-Vega, S V Kozyrev, E Sanchez, R Velazquez-Cruz, N Eriksson, J Wojcik, M V P Linga Reddy, G Lima, S D'Alfonso, et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk Ann Rheum Dis, November 1, 2009; 68(11): 1746 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. KIYOHARA, M. WASHIO, T. HORIUCHI, Y. TADA, T. ASAMI, S. IDE, T. ATSUMI, G. KOBASHI, and H. TAKAHASHI Cigarette Smoking, STAT4 and TNFRSF1B Polymorphisms, and Systemic Lupus Erythematosus in a Japanese Population J Rheumatol, October 1, 2009; 36(10): 2195 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meroni, A Tincani, M. Alarcon-Riquelme, Y Shoenfeld, and M. Borghi European Forum on Antiphospholipid Antibodies: research in progress Lupus, September 1, 2009; 18(10): 924 - 929. [Abstract] [PDF]
|
|
|
|
|
|
A. HELLQUIST, T. M. JARVINEN, S. KOSKENMIES, M. ZUCCHELLI, C. ORSMARK-PIETRAS, L. BERGLIND, J. PANELIUS, T. HASAN, H. JULKUNEN, M. D'AMATO, et al. Evidence for Genetic Association and Interaction Between the TYK2 and IRF5 Genes in Systemic Lupus Erythematosus J Rheumatol, August 1, 2009; 36(8): 1631 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rueda, J. Broen, C. Simeon, R. Hesselstrand, B. Diaz, H. Suarez, N. Ortego-Centeno, G. Riemekasten, V. Fonollosa, M.C. Vonk, et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype Hum. Mol. Genet., June 1, 2009; 18(11): 2071 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Kariuki, K. A. Kirou, E. J. MacDermott, L. Barillas-Arias, M. K. Crow, and T. B. Niewold Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-{alpha} in Lupus Patients In Vivo J. Immunol., January 1, 2009; 182(1): 34 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Verlaan, B. Ge, E. Grundberg, R. Hoberman, K. C.L. Lam, V. Koka, J. Dias, S. Gurd, N. W. Martin, H. Mallmin, et al. Targeted screening of cis-regulatory variation in human haplotypes Genome Res., January 1, 2009; 19(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|